Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Sokratis Papageorgiou"'
Autor:
Anastasia Bougea, Efthalia Angelopoulou, Efthimios Vasilopoulos, Philippos Gourzis, Sokratis Papageorgiou
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 12, p 6542 (2024)
Fluoxetine, a commonly prescribed medication for depression, has been studied in Alzheimer’s disease (AD) patients for its effectiveness on cognitive symptoms. The aim of this systematic review is to investigate the therapeutic potential of fluoxet
Externí odkaz:
https://doaj.org/article/1d3075f3104f448885857b9233d56b41
Autor:
Efthalia Angelopoulou, Anastasia Bougea, Alexandros Hatzimanolis, Leonidas Stefanis, Nikolaos Scarmeas, Sokratis Papageorgiou
Publikováno v:
Medicina, Vol 60, Iss 1, p 115 (2024)
Neuropsychiatric symptoms (NPS), including depression, anxiety, apathy, visual hallucinations, and impulse control disorders, are very common during the course of Parkinson’s disease (PD), occurring even at the prodromal and premotor stages. Mild b
Externí odkaz:
https://doaj.org/article/02f409599dbe4dee92497f732eb04414
Autor:
Vasilios C. Constantinides, Fotini Boufidou, Mara Bourbouli, Efstratios-Stylianos Pyrgelis, Apostolia Ghika, Christos Koros, George Liakakis, Sokratis Papageorgiou, Leonidas Stefanis, George P. Paraskevas, Elisabeth Kapaki
Publikováno v:
Diagnostics, Vol 13, Iss 3, p 332 (2023)
Background: Patients with a frontotemporal lobar degeneration (FTLD) usually manifest with behavioral variant frontotemporal dementia (bvFTD). Alzheimer’s disease (AD) may also manifest with a predominant behavioral-dysexecutive syndrome, similar t
Externí odkaz:
https://doaj.org/article/431f841ea6f14b6f9c91c8fc9899ed33
Autor:
Efthalia Angelopoulou, Nikolaos Papachristou, Anastasia Bougea, Evangelia Stanitsa, Dionysia Kontaxopoulou, Stella Fragkiadaki, Dimosthenis Pavlou, Christos Koros, Yıldız Değirmenci, John Papatriantafyllou, Eleftherios Thireos, Antonios Politis, Agis Tsouros, Panagiotis Bamidis, Leonidas Stefanis, Sokratis Papageorgiou
Publikováno v:
Medicina, Vol 58, Iss 12, p 1705 (2022)
Background and Objectives: Dementia affects more than 55 million patients worldwide, with a significant societal, economic, and psychological impact. However, many patients with Alzheimer’s disease (AD) and other related dementias have limited acce
Externí odkaz:
https://doaj.org/article/44f5dccc4aa24d9a8bf3bd8cd0caa12f
Autor:
Tatiana Dimitriou, Theodore Parthimos, Vasiliki Kamtsadeli, Niki Tsinia, Maria Hatzopoulou, Evi Lykou, Lina Chatziantoniou, Olga Papatriantafyllou, Chara Tzavara, Panagiotis Zikos, Sokratis Papageorgiou, Bruce Miller, Kate Rankin, John Papatriantafyllou
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 24; Pages: 7375
Journal of clinical medicine, vol 11, iss 24
Journal of clinical medicine, vol 11, iss 24
Background: Social cognition helps people to understand their own and others’ behavior and to modulate the way of thinking and acting in different social situations. Rapid and accurate diagnoses of neurodegenerative diseases are essential, as socia
Publikováno v:
Brain sciences. 12(2)
Parkinson’s disease (PD) is the second most common neurodegenerative disorder with an unclear etiology and no disease-modifying treatment to date. PD is considered a multifactorial disease, since both genetic and environmental factors contribute to
Publikováno v:
Genes. 13:1099
Psychosis in Parkinson’s disease (PDP) represents a common and debilitating condition that complicates Parkinson’s disease (PD), mainly in the later stages. The spectrum of psychotic symptoms are heterogeneous, ranging from minor phenomena of mil
Autor:
Georgios Tsivgoulis, Christos Krogias, Georgios S Georgiadis, Robert Mikulik, Dimitrios Athanasiadis, Apostolos Safouris, Sakia H Meves, Konstantinos Vadikolias, Konstantinos Voumvourakis, Michal Haršány, Ioannis Heliopoulos, Sokratis Papageorgiou, Efstratios Georgakarakos, Ekaterini-Christina Tampaki, Andreas Lazaris, Charitomeni Piperidou, Elefterios Stamboulis, Leonidas Stefanis, Miltos Lazarides, Spyros N Vasdekis
Publikováno v:
Stroke. 45
Background&Purpose: Although the latest AHA recommendations suggest that CEA should be performed within two weeks of the index event in patients with sCAS, only a minority of patients undergoes surgery within the recommended time-frame because of a p
Autor:
Sokratis Papageorgiou, John Papatriantafyllou, Apostolia Ghika, Theodoros Kontaxis, Niki Tsinia, Eudoxia Lykou, Evaggelia Hatziantoniou, Dimitrios Agiomyrgiannakis, Andreas Kyrozis
Publikováno v:
Alzheimer's & Dementia. 7
Autor:
Delforge, J., Spelle, L., Bendriem, B., Samson, Y., Bottlaender, M., Sokratis Papageorgiou, Syrota, A.
Publikováno v:
Europe PubMed Central
Scopus-Elsevier
Scopus-Elsevier
The in vivo quantification of the benzodiazepine receptor concentration in humans using PET and flumazenil (FMZ) is usually based on Scatchard analysis when the goal is to avoid blood sampling. The experimental protocols, however, include several (at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::d6d3307879061009abfa2e34d3f7ef41
http://europepmc.org/abstract/med/8544001
http://europepmc.org/abstract/med/8544001